Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Michael Flentje

Showing results (1-10 of 257) with videos related to

Pageof 26
Sort By:
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2003
[Present status of treatment in nasopharyngeal carcinoma?]Gabriele Beckmann, Michael Flentje
Future Oncology (London, England)|February 7, 2007
Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancerMatthias Guckenberger, Michael Flentje
International Journal of Colorectal Disease|July 30, 2005
Late small bowel toxicity after adjuvant treatment for rectal cancerMatthias Guckenberger, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 9, 2022
[Salvage prostate bed radiotherapy: co-irradiation of regional LNs and significance of ADT]Felix Grabenbauer, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 8, 2021
Michael Flentje, Jürgen Richter
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 13, 2007
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectivesMatthias Guckenberger, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 23, 2023
[Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study]Felix Grabenbauer, Michael Flentje
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 22, 2002
Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the Comet assayCholpon S Djuzenova, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 14, 2018
MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancerJörg Tamihardja, Maria Zenk, Michael Flentje
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 24, 2003
[Emotional distress and needs for psychosocial support among breast cancer patients at start of radiotherapy]Hermann Faller, Barbara Olshausen, Michael Flentje
Pageof 26

Showing results (1-10 of 257) with videos related to

Sort By:
Pageof 26
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|May 13, 2003
[Present status of treatment in nasopharyngeal carcinoma?]Gabriele Beckmann, Michael Flentje
Future Oncology (London, England)|February 7, 2007
Intensity-modulated radiotherapy for the treatment of pelvic lymph nodes in prostate cancerMatthias Guckenberger, Michael Flentje
International Journal of Colorectal Disease|July 30, 2005
Late small bowel toxicity after adjuvant treatment for rectal cancerMatthias Guckenberger, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 9, 2022
[Salvage prostate bed radiotherapy: co-irradiation of regional LNs and significance of ADT]Felix Grabenbauer, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|June 8, 2021
Michael Flentje, Jürgen Richter
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 13, 2007
Intensity-modulated radiotherapy (IMRT) of localized prostate cancer: a review and future perspectivesMatthias Guckenberger, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|February 23, 2023
[Organ-preserving treatment of muscle-invasive bladder cancer: 10-year data of the British BC2001 study]Felix Grabenbauer, Michael Flentje
Medical Science Monitor : International Medical Journal of Experimental and Clinical Research|October 22, 2002
Characterization of Fanconi anemia fibroblasts in terms of clonogenic survival and DNA damage assessed by the Comet assayCholpon S Djuzenova, Michael Flentje
Strahlentherapie Und Onkologie : Organ Der Deutschen Rontgengesellschaft ... [Et Al]|September 14, 2018
MRI-guided localization of the dominant intraprostatic lesion and dose analysis of volumetric modulated arc therapy planning for prostate cancerJörg Tamihardja, Maria Zenk, Michael Flentje
Psychotherapie, Psychosomatik, Medizinische Psychologie|April 24, 2003
[Emotional distress and needs for psychosocial support among breast cancer patients at start of radiotherapy]Hermann Faller, Barbara Olshausen, Michael Flentje
Pageof 26